Skip to main content
. Author manuscript; available in PMC: 2015 Jul 1.
Published in final edited form as: Contemp Clin Trials. 2014 Jun 14;38(2):321–332. doi: 10.1016/j.cct.2014.06.003

Table 1.

Measures and Schedule

Baseline Weekly (1–8) Week 8 Month s 3, 6, 12 Follow -up
Smoking Outcomes
Current smoking s, x x x x
CO Interview: current smoking, CO, adverse events x
Saliva cotinine x x6m,12m
Smoking Covariates
Smoking History x
Fagerstrom Nicotine Dependence (FTND) x x x
Withdrawal symptoms, medication use x x x x
Readiness, confidence, stage of change x x x
Smoking Situations Temptations (SST), Smoking Risk x
Smoking for Weight Control (SSQ) x x x
Social Support for Quitting (family / friends) x
Smoking locus of control (LOC) x x
Other Covariates
Demographics x
Height, Weight, BMI x
Affect & Anxiety: Stait, CESD-10, PANAS x x x
Five Facet Mindfulness Questionnaire (FFMQ-15) x x x
Barratt Impulsiveness Scale (BIS) x x x
Interpersonal Support Evaluation (ISEL) x
Outcome Expectations for Yoga x
Yoga Expectations x
Physical Activity and Health
PAR-Q S
7-day PAR & Stages of Change x x x
Yoga Logs (yoga arm) x M1–12
Heath behavior Logs (wellness arm) M1–12
ATSQ and SF-8 health status questionnaire x x x
Current health status and health history S
Process Measures and Program Evaluation
Program attendance (weeks 1–8) x
Group Cohesion Survey x
Group leader evaluations (SCC, Yoga, CTL) x
Focus groups x
Interviews x6m
Quality Control
Audit 20% of SCC class tapes Quarterly
Data Safety Management Board Quarterly
External independent audit Annually
IRB review Annually
IRB audit of consent documents Periodic

S = Screening; M = monthly during months 1-12; x6m = at six months only; x6m,12m = at six and 12 months only